
Schedule your safe, non-surgical piles treatment with our expert doctors. Secure booking with instant confirmation.
Select your preferred date and time, choose your service, and book your appointment securely.
Your booking is secure and you will receive instant confirmation via email and SMS.
Spread the cost of your treatment over 6 months with 0% interest. No extra charges — pay the same price, just in manageable monthly instalments.

Prorecta Clinic LTD is a credit broker, not a lender. We do not charge you for credit broking services. We will introduce you to loan products provided by Buyline Ltd. Finance is subject to application, your financial circumstances and borrowing history. Finance is only available to UK residents over the age of 18. Terms and conditions apply.
0% finance with a term of 11 months or less is not regulated by the Financial Conduct Authority.
Buyline Ltd is authorised and regulated by the Financial Conduct Authority. Firm Reference Number 805162. Registered office: B12 Elmbridge Court, Cheltenham Road East, Gloucester, GL3 1JZ.
Fill in your details below to apply for 0% finance
Our advanced non-surgical piles treatment offers a safe, effective and minimally invasive solution for haemorrhoids, including prolapsed haemorrhoids, with minimal downtime and long term results. Unlike temporary solutions like piles cream or haemorrhoids cream, our treatment provides long term relief.
Our specialists assess your condition with a proctoscopy, and if piles are present, we offer eXroid treatment.
The low electrical current stimulates a chemical reaction, which seals off the feeding blood vessels.
Across a four week period post treatment your haemorrhoids will begin to shrink as blood vessels feeding the haemorrhoid are sealed off.
Direct Current Electrotherapy (DCE) was first used as a treatment for the management of internal haemorrhoids in the 19th century, with the first medical publication in 1867 on the use of galvanic current to treat internal haemorrhoids. The subsequent history of the use of DCE is an interesting one. Attempts at commercialising the technology have been made in the past with the Keesey machine in the 1920's and the Ultroid device developed in the late 1980's.
When it was realised that there were no manufacturers of the technology from whom to source a DCE device, eXroid Technology Ltd was established and completed the design, development and manufacture of the eXroid Haemorrhoid Treatment System in the UK. It gained its ISO13485:2016 and CE accreditations before being launched into clinical use in March 2019 in the UK.
Previously, the National Institute for Health and Care Excellence (NICE) had recognised DCE as a safe and effective treatment for treating internal haemorrhoids from grades 1-3, with guidance being published in June 2015. In December 2019, NICE then published a MedTech Innovation Briefing (MIB201) which provided guidance that stated that the eXroid brand of DCE was safe and effective and could be used to treat patients suffering from internal haemorrhoids grade 1-3.
NICE stated they wanted to see more peer-reviewed and published data before it would add grade 4 to the guidance as well. In the USA, however, the FDA (the Food and Drug Administration), has issued approval for the use of DCE to treat all 4 grades of haemorrhoid, indeed, it is the only treatment for haemorrhoids that has been so classified in the USA.
NICE Guidance (2015)
Approved for grades 1-3 haemorrhoids
NICE MIB201 (2019)
eXroid brand specifically approved
FDA Approval (USA)
All 4 grades of haemorrhoids
ISO13485:2016 & CE
Quality management certification
Patient experience is at the heart of everything we do. Here's what some of our patients have to say about their treatment.
These patient stories are from people treated with the eXroid procedure.